GlassScriptPhysician profile
Geoffrey Zimmerman
NPI 1851320014
$1,563.55
in general payments reported to CMS, 2019-2025
26 companies · $75.71 in 2025
The $75.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $269 · 2021: $227 · 2022: $187 · 2023: $103 · 2024: $112 · 2025: $75.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $507.75 | 2019-2020 | |
| Abbvie INC. | $204.80 | 2020-2025 | Liletta |
| Minerva Surgical, INC | $121.16 | 2019 | |
| Therapeuticsmd, INC. | $111.90 | 2020-2022 | |
| Evofem Biosciences, INC. | $99.67 | 2021-2024 | Phexxi |
| Shield Therapeutics INC | $56.35 | 2022-2025 | |
| Exeltis, USA INC. | $51.39 | 2021-2022 | |
| Hologic Sales and Service, LLC | $43.59 | 2023 | Thinprep 2000 Processor, Aptima |
| Optumhealth Care Solutions, LLC | $40.83 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pfizer INC. | $39.16 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.05 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.79 | 2020 | |
| Lupin INC. | $23.73 | 2021 | |
| Aspira Women'S Health INC | $21.91 | 2024 | Ova1 |
| Boston Scientific Corporation | $21.65 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.33 | 2025 | Exparel |
| Coopersurgical, INC. | $19.51 | 2022 | |
| Allergan, INC. | $14.94 | 2019 | |
| Convatec INC. | $14.13 | 2022 | |
| Myovant Sciences INC. | $14.06 | 2021 | |
| Roche Diagnostics Corporation | $13.77 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.28 | 2019 | |
| Scynexis, INC. | $12.99 | 2022 | |
| Mayne Pharma Commercial LLC | $12.72 | 2021 | |
| Medicem INC. | $11.27 | 2021 | |
| Mission Pharmacal Company | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.